Faculty Opinions recommendation of Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.
Keyword(s):
2014 ◽
Vol 5
(5)
◽
pp. 474-479
◽
Keyword(s):
2019 ◽
Vol 47
(8)
◽
pp. 874-882
◽
Keyword(s):
2016 ◽
Vol 83
(2)
◽
pp. 326-338
◽
Keyword(s):
2015 ◽
Vol 407
(19)
◽
pp. 5603-5613
◽
2008 ◽
Vol 327
(3)
◽
pp. 898-909
◽